en
lv
ru
Investors
Corporate Governance
Financial Information
Financial News
Presentations
Documents
Information on Shares
Analysts
Shareholders’ Meetings
Investor contacts
Media
Latest News
Photo Library
Media Contacts
Careers
Personnel Policy
Vacancies
Application Form
Internship
Career Contacts
Contacts
Search
Home
Company
About Olainfarm
Business Strategy
Governance and Management
Structure
Supervisory Council
Board
Senior Executive Team
Olainfarm Worldwide
Responsibility
Licences and Certificates
Quality Policy
Environment Protection Policy
Participation in Projects
Ongoing projects
Completed projects
Awards
History
In memoriam
Products and Services
Products
Over the Counter (OTC)
Prescription Medicines
Food Supplements
APIs and Intermediates
APIs
Intermediates
Services
QC/QA Services
Regulatory Services
APIs and Intermediates Development
Final Dosage Forms Development
Contract Manufacturing
Research and Development
R&D of APIs and Intermediates
R&D of Final Dosage Forms
Preclinical Trials
Clinical Trials
Cooperation
Investors
Investors
07.25.2015
Investors
Corporate Governance
Financial Information
Financial News
Presentations
Documents
Shareholders’ Meetings
Investor Contacts
Information on Shares
Analysts
Search
Recent Posts
Sales of Olainfarm in October Grew by 34%
November 15, 2018
On Transactions Under Regulation No 596/2014
November 14, 2018
On Transactions Under Regulation No 596/2014
November 14, 2018
About acquisition of significant shareholding
November 14, 2018
Change in significant shareholding
November 14, 2018
